GLYC - GlycoMimetics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue-18.520,070.7515,027.004
Cost of Revenue----
Gross Profit-18.520,070.7515,027.004
Operating Expenses
Research Development24,100.09223,281.8225,050.17919,571.073
Selling General and Administrative9,832.1888,650.1657,805.3966,595.738
Non Recurring----
Others----
Total Operating Expenses33,932.2831,931.98532,855.57526,166.811
Operating Income or Loss-33,932.28-31,913.485-12,784.825-11,139.807
Income from Continuing Operations
Total Other Income/Expenses Net651.212103.64715.32718.241
Earnings Before Interest and Taxes-33,932.28-31,913.485-12,784.825-11,139.807
Interest Expense----
Income Before Tax-33,281.068-31,809.838-12,769.498-11,121.566
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-33,281.068-31,809.838-12,769.498-11,121.566
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-33,281.068-31,809.838-12,769.498-11,121.566
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-33,281.068-31,809.838-12,769.498-11,121.566